However, since NF-κB modulates Beta-Secretase 1 (BACE1) expression, closely related to AD [69], and inhibition of NF-κB prevents neuronal apoptosis in different neurodegenerative disorders [70], targeting NF-κB signaling again opens promising therapeutical options. The gene discussed is BACE1; the disease is Alzheimer disease.